EP1409655A4 - Proteines de la superfamille des immunoglobulines - Google Patents
Proteines de la superfamille des immunoglobulinesInfo
- Publication number
- EP1409655A4 EP1409655A4 EP02726671A EP02726671A EP1409655A4 EP 1409655 A4 EP1409655 A4 EP 1409655A4 EP 02726671 A EP02726671 A EP 02726671A EP 02726671 A EP02726671 A EP 02726671A EP 1409655 A4 EP1409655 A4 EP 1409655A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- immunoglobulin superfamily
- superfamily proteins
- proteins
- immunoglobulin
- superfamily
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108060003951 Immunoglobulin Proteins 0.000 title 1
- 102000018358 immunoglobulin Human genes 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Psychology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Cell Biology (AREA)
Applications Claiming Priority (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27524901P | 2001-03-12 | 2001-03-12 | |
US275249P | 2001-03-12 | ||
US31681001P | 2001-08-31 | 2001-08-31 | |
US316810P | 2001-08-31 | ||
US32397701P | 2001-09-21 | 2001-09-21 | |
US323977P | 2001-09-21 | ||
US34844701P | 2001-10-26 | 2001-10-26 | |
US348447P | 2001-10-26 | ||
US34388001P | 2001-11-02 | 2001-11-02 | |
US343880P | 2001-11-02 | ||
PCT/US2002/009052 WO2002072794A2 (fr) | 2001-03-12 | 2002-03-12 | Proteines de la superfamille des immunoglobulines |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1409655A2 EP1409655A2 (fr) | 2004-04-21 |
EP1409655A4 true EP1409655A4 (fr) | 2005-04-06 |
Family
ID=27540591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02726671A Withdrawn EP1409655A4 (fr) | 2001-03-12 | 2002-03-12 | Proteines de la superfamille des immunoglobulines |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1409655A4 (fr) |
JP (1) | JP2004533222A (fr) |
AU (1) | AU2002257088A1 (fr) |
CA (1) | CA2440618A1 (fr) |
WO (1) | WO2002072794A2 (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1434783A4 (fr) * | 2001-03-16 | 2006-06-07 | Lilly Co Eli | Proteines de mammiferes lp et reactifs associes |
MXPA04001986A (es) * | 2001-08-29 | 2004-06-07 | Genentech Inc | Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad. |
WO2007001459A2 (fr) | 2004-11-15 | 2007-01-04 | Washington University | Compositions et procedes pour moduler l'activite lymphocytaire |
WO2004000221A2 (fr) * | 2002-06-20 | 2003-12-31 | The Regents Of The University Of California | Compositions et procedes de modulation de l'activite lymphocytaire |
US8546541B2 (en) | 2002-06-20 | 2013-10-01 | Washington University | Compositions and methods for modulating lymphocyte activity |
JP2006515167A (ja) * | 2002-10-25 | 2006-05-25 | ジェネンテック・インコーポレーテッド | 免疫関連疾患の治療のための新規組成物と方法 |
US20040109863A1 (en) * | 2002-12-04 | 2004-06-10 | Peter Emtage | Methods of therapy and diagnosis using targeting of cells that express Ly-9 |
US20040248257A1 (en) * | 2003-04-30 | 2004-12-09 | The Scripps Research Institute | SPEX compositions and methods of use |
KR101224659B1 (ko) * | 2004-11-12 | 2013-01-21 | 제넨테크, 인크. | 면역 관련 질환의 치료를 위한 신규 조성물 및 방법 |
US8303952B2 (en) | 2009-06-08 | 2012-11-06 | Washington University | Methods for inducing in vivo tolerance |
CA2893977C (fr) | 2012-12-21 | 2024-02-13 | Seattle Genetics, Inc. | Anticorps anti-ntb-a et compositions et procedes associes |
CN105793284A (zh) * | 2013-09-17 | 2016-07-20 | 大学健康网络(Uhn):技术开发和商业化公司 | 针对顺式RGMa/再生蛋白相互作用或脂筏的试剂及其在治疗方法中的应用 |
EP2905622A1 (fr) * | 2014-02-07 | 2015-08-12 | Institut D'Investigaciones Biomédiques August Pi i Sunyer | Diagnostic d'une maladie neurologique |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000029583A2 (fr) * | 1998-11-19 | 2000-05-25 | Incyte Pharmaceuticals, Inc. | Proteines de la superfamille des immunoglobulines |
WO2000055371A1 (fr) * | 1999-03-18 | 2000-09-21 | Human Genome Sciences, Inc. | 27 proteines humaines secretees |
WO2001040466A2 (fr) * | 1999-12-01 | 2001-06-07 | Genentech, Inc. | Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides |
WO2001068848A2 (fr) * | 2000-03-01 | 2001-09-20 | Genentech, Inc. | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
WO2002000691A2 (fr) * | 2000-06-27 | 2002-01-03 | Curagen Corporation | Nouveaux polynucleotides et polypeptides codes par ceux-ci |
WO2002062999A2 (fr) * | 2000-12-29 | 2002-08-15 | Curagen Corporation | Proteines et acides nucleiques codant pour celles-ci |
WO2002099040A2 (fr) * | 2001-06-05 | 2002-12-12 | Exelixis, Inc. | Ig utilises comme modificateurs de la voie p53 et methodes d'utilisation associees |
-
2002
- 2002-03-12 WO PCT/US2002/009052 patent/WO2002072794A2/fr not_active Application Discontinuation
- 2002-03-12 JP JP2002571850A patent/JP2004533222A/ja active Pending
- 2002-03-12 EP EP02726671A patent/EP1409655A4/fr not_active Withdrawn
- 2002-03-12 AU AU2002257088A patent/AU2002257088A1/en not_active Abandoned
- 2002-03-12 CA CA002440618A patent/CA2440618A1/fr not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000029583A2 (fr) * | 1998-11-19 | 2000-05-25 | Incyte Pharmaceuticals, Inc. | Proteines de la superfamille des immunoglobulines |
WO2000055371A1 (fr) * | 1999-03-18 | 2000-09-21 | Human Genome Sciences, Inc. | 27 proteines humaines secretees |
WO2001040466A2 (fr) * | 1999-12-01 | 2001-06-07 | Genentech, Inc. | Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides |
WO2001068848A2 (fr) * | 2000-03-01 | 2001-09-20 | Genentech, Inc. | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
WO2002000691A2 (fr) * | 2000-06-27 | 2002-01-03 | Curagen Corporation | Nouveaux polynucleotides et polypeptides codes par ceux-ci |
WO2002062999A2 (fr) * | 2000-12-29 | 2002-08-15 | Curagen Corporation | Proteines et acides nucleiques codant pour celles-ci |
WO2002099040A2 (fr) * | 2001-06-05 | 2002-12-12 | Exelixis, Inc. | Ig utilises comme modificateurs de la voie p53 et methodes d'utilisation associees |
Non-Patent Citations (5)
Title |
---|
DATABASE EMBL [online] 14 July 2000 (2000-07-14), "601194074F1 NIH_MGC_7 Homo sapiens cDNA clone IMAGE:3537763 5', mRNA sequence.", XP002304382, retrieved from EBI accession no. EM_PRO:BE264969 Database accession no. BE264969 * |
DATABASE EMBL [online] 18 April 1997 (1997-04-18), "EST59829 Infant brain Homo sapiens cDNA 5' end.", XP002304381, retrieved from EBI accession no. EM_PRO:AA351918 Database accession no. AA351918 * |
DATABASE EMBL [online] 21 November 2002 (2002-11-21), "Homo sapiens NPEH2 (NEPH2) mRNA, complete cds.", XP002304383, retrieved from EBI accession no. EM_PRO:AF480410 Database accession no. AF480410 * |
DATABASE EMBL [online] 3 December 1999 (1999-12-03), "Homo sapiens genomic DNA, chromosome 11q, clone:RP11-713C6.", XP002304380, retrieved from EBI accession no. EM_HUM:AP000806 Database accession no. AP000806 * |
SELLIN LORENZ ET AL: "NEPH1 defines a novel family of podocin interacting proteins.", THE FASEB JOURNAL : OFFICIAL PUBLICATION OF THE FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY. JAN 2003, vol. 17, no. 1, January 2003 (2003-01-01), pages 115 - 117, XP002304379, ISSN: 1530-6860 * |
Also Published As
Publication number | Publication date |
---|---|
EP1409655A2 (fr) | 2004-04-21 |
JP2004533222A (ja) | 2004-11-04 |
CA2440618A1 (fr) | 2002-09-19 |
AU2002257088A1 (en) | 2002-09-24 |
WO2002072794A3 (fr) | 2004-01-29 |
WO2002072794A2 (fr) | 2002-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0130228D0 (en) | Protein | |
EP1365022A4 (fr) | Proteine associee a l'adiponectine | |
GB0130557D0 (en) | Proteins | |
GB0108079D0 (en) | Protein | |
EP1409655A4 (fr) | Proteines de la superfamille des immunoglobulines | |
GB0130720D0 (en) | Proteins | |
AU2002219974A1 (en) | Immunoglobulin superfamily proteins | |
EP1373306A4 (fr) | Proteines associees au cytoskeleton | |
GB0128161D0 (en) | Receptor protein | |
GB0130560D0 (en) | Proteins | |
AU2002326909A8 (en) | Neurotransmission-associated proteins | |
GB0106318D0 (en) | Protein | |
GB0130721D0 (en) | Protein | |
GB0130743D0 (en) | Proteins | |
GB0108472D0 (en) | Proteins | |
GB0130384D0 (en) | Proteins | |
GB0128374D0 (en) | Proteins | |
GB0125514D0 (en) | Proteins | |
GB0130719D0 (en) | Proteins | |
GB0120557D0 (en) | Proteins | |
GB0130722D0 (en) | Proteins | |
GB0130739D0 (en) | Proteins | |
GB0130742D0 (en) | Proteins | |
GB0114313D0 (en) | Proteins | |
GB0130718D0 (en) | Proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20030924 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7C 12N 15/12 B Ipc: 7C 07K 14/47 A |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20050221 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20050512 |